HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis

Hepatology

Volumn 41, Issue 4, 2005, Pages 779-789

  Pineda, Juan A ^a   Romero Gómez, Manuel ^a   Díaz García, Fernando ^b   Girón González, José A ^b   Montero, José L ^c   Torre Cisneros, Julián ^c   Andrade, Raúl J ^d   González Serrano, Mercedes ^d   Aguilar, José ^e   Aguilar Guisado, Manuela ^e   Navarro, José M ^f   Salmerón, Javier ^g   Caballero Granado, Francisco J ^h   García García, José A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL COSTA DEL SOL   (Spain)

^g HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^h HOSPITAL PUNTA DE EUROPA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL TIME;

ADULT; AGED; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HEPATITIS C; HEPATITIS D; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 20144388976     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20626     Document Type: Article

References (38)

1. Benhamou Y, Bochet M, di Martino V, Charlotte F, Azria F, Coutelier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. HEPATOLOGY 1999;30:1054-1058.
2. Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003;52:1035-1040.
3. Martínez-Sierra C, Arizcorreta A, Díaz F, Roldán R, Martín-Herrera L, Pérez-Guzmán E, et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003;36:491-498.
4. Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 2001;183:1112-1115.
5. Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC 2nd, et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002;100:1584-1589.
6. Darby SC, Ewart DW, Giangrande PL, Spooner RJD, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350:1425-1431.
7. Qurishi N, Kreuzberg C, Luchters G, Effenberger W, Kupfer B, Sauerbruch T, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003;362:1708-1713.
8. Smukler AJ, Ratner L. Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients. Curr Opin Oncol 2002;14:538-542.
9. Macias J, Melguizo I, Fernândez Rivera J, Garcia-Garcia A, Mira JA, Ramos AJ, et al. Mortality due to liver failure and impact on survival of hepatitis C virus infection in HIV-infected patients receiving potent antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2002;21:775-781.
10. Rosenthal E, Poiree M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L, et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003;17:1803-1809.
11. Garcia-Samaniego J, Soriano V, Miro JM, del Romero J, Bruguera M, Castilla J, et al. Management of chronic viral hepatitis in HIV-infected patients: Spanish consensus conferences. HIV Clin Trials 2002;3:99-114.
12. Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, et al. Care of patients with hepatitis C and HIV coinfection. AIDS 2004;18:1-12.
13. Ragni MV, Belle SH, Im K, Neff G, Roland M, Stock P, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003:188:1412-1420.
14. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-852.
15. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. HEPATOLOGY 1996;23:164-176.
16. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000;32:142-153.
17. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-430.
18. Ginés P, Guevara M, Arroyo V, Rodés J. Hepatorenal syndrome. Lancet 2003;362:1819-1827.
19. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001;33:464-470.
20. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003;138:197-207.
21. Thomas DL. Hepatitis C and human immunodeficiency virus infection. HEPATOLOGY 2002;36(Suppl 1):S201-S209.
22. Munshi N, Balasubramanian A, Koziel M, Ganju RK, Groopman JE. Hepatitis C and human immunodeficiency virtis envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 2003;188:1192-1204.
23. Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol 2003;37:400-410.
24. Macias J, Castellano V, Merchante N, Palacios RB, Mira JA, Sáez C, et al. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS 2004;18:767-774.
25. Planas R, Balleste B, Alvarez MA, Rivera M, Montoliu S, Caleras JA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004;40:823-830.
26. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.
27. Said A, Williams J, Holden J, Remington P, Gangon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.
28. Fontana RJ. Management of patients with decompensated HBV cirrhosis. Semin Liver Dis 2003;23:89-100.
29. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999;30:890-895.
30. Romero-Gómez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. HEPATOLOGY 2004;39:939-943.
31. Degos F. Hepatitis C and alcohol. J Hepatol 1999;31(Suppl 1):113-118.
32. Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, et al. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. HEPATOLOGY 2002;35:1247-1255.
33. Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003;124:97-104.
34. Tural C, Fusrer D, Tor J, Ojanguren I, Sirera G, Ballesteros A, et al. Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients. J Viral Hepat 2003;10:118-125.
35. Orrego H, Blake JE, Blendis LM, Kapur BM, Israel Y. Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 1979;2:1354-1356.
36. García-Samaniego J, Rodríguez M, Berenguer J, Rodríguez-Rosado R, Carbó J, Asensi V, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001;96:179-183.
37. Soriano V, Miró JM, García-Samaniego J, Torre-Cisneros J, Núnez M, del Romero J, et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat 2004;11:2-17.
38. Miró JM. Documento-guía para el trasplante de órganos sólidos en pacientes infectados por el VIH. GESIDA/GESITRA/PNS/ONT, II Encuentro de GESIDA, November 7-8, 2003, San Sebastián, Spain. Available at: http://www.gesidaseimc.com/.